Dexcom (DXCM) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 27, 2026, to be held virtually for shareholders of record as of April 1, 2026.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request by May 15, 2026.

Voting matters and shareholder proposals

• Shareholders will vote to elect twelve director nominees to serve until the 2027 annual meeting.

• Proposal to ratify Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Advisory vote on executive compensation for the fiscal year ended December 31, 2025.

• Other business may be addressed if properly brought before the meeting.

Board of directors and corporate governance

• Twelve nominees are presented for election to the board, including Steven Altman, Dr. Euan Ashley, Nicholas Augustinos, Richard Collins, Rimma Driscoll, Mark Foletta, Renée Galá, Bridgette Heller, Jacob Leach, Kyle Malady, Rick Osterloh, and Kevin Sayer.